The Wand® provides comfortable, effective, painless anesthesia and a safer, more comfortable experience
Milestone Scientific Inc. (NYSE:MLSS), a dental and medical company that develops and commercializes a growing portfolio of proprietary injection technologies, today announced that The Brookdale University Hospital and Medical Center in New York will now utilize The Wand® computer assisted anesthesia system for its advanced education program in Pediatric Dentistry. In addition, The Wand® will be incorporated into regular use in the Department of Dental Medicine & Oral Maxillofacial Surgery.
The Wand was featured last evening in a related WCBS-TV New York news report that was shot on site at Brookdale. A link to the news report is available at: http://newyork.cbslocal.com/video/3860172-new-device-offers-gentler-experience-when-going-to-the-dentist/
The Brookdale University Hospital and Medical Center is one of the largest nonprofit voluntary teaching hospitals in Brooklyn. It is comprised of a ten-acre campus and six family care centers. Its Pediatric Dentistry practice has over 7,000 patient visits per year.
“Providing the most advanced technology for training and patient care services is part of our commitment to promote and facilitate the highest level of care to the communities we serve,” said Dr. Sheeba Kurian, Brookdale’s Program Director, Advanced Education Program in Pediatric Dentistry. “We are particularly interested in exposing and training our residents to the newest and most patient-friendly technologies such as The Wand® because they help produce good results and pleasant patient experiences. That means our patients will return to us and are more likely to take preventative measures resulting in better outcomes.”
Gian Domenico Trombetta, CEO of Wand Dental, Inc. and a director of Milestone Scientific, commented, “Brookdale University Hospital and Medical Center is the most recent addition to dental residency programs and clinics that have adopted The Wand® and are making it part of their curriculum and ongoing practice. Parents and children are special beneficiaries from the technology as it delivers comfortable and effective anesthesias (including single tooth anesthesia), providing a safer, painless and more pleasant experience. It is gratifying to see our technology incorporated into the curriculum for specialty residents. They represent the next generation of dental specialists and we anticipate they will become lifetime users of The Wand® once they experience the advantages for both patients and dentists when using our technology.”
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs innovative injection technologies with 20 patents to its credit. Milestone’s computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report for the year ended December 31, 2017. The forward looking statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [email protected]